Pamlab Report issue

For profit Phase 3
Founded: Covington LA United States (1986)
Status: Acquired by Nestle (2013)

Organization Overview

First Clinical Trial
2001
NCT00032435
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Pamlab, Inc. | Pamlab, L.L.C. | PAMLAB LLC | Pan American Laboratories

Active Ingredients

Marketed Drugs (1)

chlorphenesin (maolate) (1965)

Drugs in Phase 3 Trials (3)

homocysteine (1 trial)

methylfolate (3 trials)

methylphenidate (ritalin) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Attention Deficit Disorder with Hyperactivity (Phase 3)

Hyperkinesis (Phase 3)

Kidney Diseases (Phase 3)

Kidney Failure, Chronic (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 4
  • # of Trial APIs: 3